Catalysts for Ondansetron
24 tracked
Apr 27, 2026
phase 2 initiation
Chongqing Cancer Hospital — ondansetron (Phase II Trial Initiation)
ondansetron ODT
→
Nov 24, 2025
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Nov 17, 2025
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
May 31, 2024
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
May 31, 2024
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Jan 31, 2024
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Jan 31, 2024
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
May 14, 2018
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Mar 7, 2018
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Mar 27, 2017
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Mar 27, 2017
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Mar 24, 2017
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Dec 21, 2014
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Dec 21, 2014
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Dec 10, 2014
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Dec 10, 2014
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Feb 16, 2012
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Feb 16, 2012
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Oct 18, 2011
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Mar 31, 2011
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Dec 8, 2010
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Oct 29, 2010
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Apr 12, 2010
approval
ONDANSETRON — FDA approval
ondansetron ODT
→
Aug 13, 2007
approval
ONDANSETRON — FDA approval
ondansetron ODT
→